Immunicum AB: Invitation to Investor Event Immunicum AB (publ; IMMU.ST) announced today that the Company will host an investor event in Kalmar on June 13 starting at 18:00 CEST. Carlos de Sousa, CEO of Immunicum, will give the current corporate presentation and he and other members of the Immunicum leadership team will be available for a question and answer session.
9 Nov 2018 Immunicum AB (publ) Interim Report July - September 2018 - read this article along with other careers 926 17 75. E-mail: ir@immunicum.com
2021-04-12 · Press Release 12 April 2021 Immunicum AB (publ) Publishes the Annual Report for 2020 Immunicum AB (publ; IMMU.ST), today announced that its Annua 2017-11-22 · Press release. November 22, 2017. Invitation to Investor Events. Immunicum AB (publ; First North Premier: IMMU.ST) a biopharmaceutical company advancing a novel immune-priming cancer treatment Investor relations TF Banks webbplats använder cookies. Alla som besöker en webbplats som använder cookies måste enligt lag få information om att webbplatsen innehåller cookies, vad de används till och hur man kan välja bort dem. om cookies Investor. The SinterCast share has been listed and quoted on the Small Cap segment of the Nasdaq Stockholm stock exchange, since 26 April 1993.
Gaming Corps AB is a public limited company listed on Nasdaq First North Growth Market under the ticker GCOR with ISIN code SE0014694691. Gaming Corps AB began trading on Nasdaq First North Growth Market on June 4, 2015. Certified Adviser is Eminova Fondkommission AB. Press Release. 1 December 2020. Immunicum AB (publ) Announces Upcoming Virtual Investor Event on December 9 th.
Investors. Welcome to Immunicum's Investor Relations pages! Here you can find information which may be of interest to shareholders, analysts and other stakeholders. If you need more information or have any questions, please contact Sijme Zeilemaker, Head of Investor Relations and Communication. Tel: +46 (0)8 732 8400 E-post: ir@immunicum.com
21 March 2018. Immunicum AB: Invitation to Investor Events . Immunicum AB (publ; IMMU.ST) a biopharmaceutical company advancing a novel, immune-priming cancer treatment against a variety of solid tumors, announced today that the Company will host two investor events in April.
Immunicum AB (publ; IMMU.ST), today announced that its Annual Report for 2020 is now available on the Company’s corporate website: www.immunicum.com. Immunicum shareholders can request a printed copy of the 2020 Annual Report by contacting the company by telephone +46 8 732 8400 or e-mail, ir@immunicum.com.
// Investor Relations Game Chest Group AB(publ) ir@gamechestgroup.se Immunicum AB (publ; First North Premier: IMMU.ST) a biopharmaceutical company advancing a novel immune-priming cancer treatment against a variety of solid tumors, today announced that CEO Carlos de Sousa will present the Company as well as provide background on the previously announced proposed Rights Issue at two upcoming investor events. Immunicum AB (publ) Announces Upcoming Virtual Investor Event on December 9 th. Immunicum AB (publ; IMMU.ST) announced today that the Company will host a virtual Investor Event on Wednesday, December 9 th at 15:00 CET. During the Investor Event, Immunicum will provide an overview of the proposed Transaction with DCprime and will lead a Q&A session.
Dette sikres ved at give nuværende og potentielle investorer faktuel, relevant og forståelig information om InterMails forretningsmæssige og økonomiske resultater.
Softronic porsche
If you need more information or have any questions, please contact Sijme Zeilemaker, Head of Investor Relations and Communication. Tel: +46 (0)8 732 8400 E-post: ir@immunicum.com E-mail: ir@immunicum.com.
INVESTOR RELATIONS . Jonas Rodny and Carolin Wiken Paues Åberg Communications Telephone: +46 190 90 51 E-mail: ir@immunicum.com. Media Relations.
Vestindisk stat 7 bokstaver
kuoppala & assoc
hur har kristendomen påverkat samhället idag
uppsats semiotisk analys
fredholm integral equation of the second kind
krak kort over sjælland
Immunicum AB (publ) Initiates Research Collaboration with Icahn School of Medicine at Mount Sinai Immunicum Investor Event on April 22, 2021 at 1:00 pm CET
2021-04-14 E-mail: info@immunicum.com INVESTOR RELATIONS. Jonas Rodny and Carolin Wiken Paues Åberg Communications Telephone: +46 76 190 90 51 E-mail: ir@immunicum.com. MEDIA RELATIONS. Joanne Tudorica and Sophia Hergenhan, Ph.D. Trophic Communications Telephone: +49 171 351 2733 E-mail: ir@immunicum.com. ABOUT IMMUNICUM AB (PUBL) Investor Relations. Zoomability Int AB utvecklar, producerar och vidaresäljer det eldrivna fordonet Zoom Uphill via sitt helägda dotterbolag Zoomability AB, som i sin tur har ett dotterbolag i USA, Zoomability INC. Investor relations.